← Leaderboards
Steven D Dong
Kosan Biosciences, Inc.
$2,097,505
Attributed
$2,097,505
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $667.9K · FY2012–14$1M$750K$500K$250K$0
'12
'13
'14
Funding mix
By agency
NIH$2,097,505 · 2
By mechanism
R44$1,797,505 · 1
R43$300,000 · 1
Top collaborators
No co-investigators on record.
Most similar at Kosan Biosciences, Inc.
Same institution · by research overlap
- Hugo Gramajo$568,571
- David C Myles$675,000
- Robert N McDaniel$1,243,574
- James Kealey$750,000
- Leonard Katz$2,330,055
Others in their field
Top investigators on “Gold”
- David D. McManus · Univ Of Massachusetts Med Sch Worcester$41,448,114
- Bryan O Buchholz · University Of Massachusetts Lowell$40,621,016
- Kevin T Lesko · University Of California-Berkeley$39,551,398
- Salim S Abdool Karim · Columbia University Health Sciences$35,423,130
- Peter D Karp · Sri International$31,773,599
- Prescott G Woodruff · University Of California San Francisco$31,083,084
Research focus
GoldAntigensAntibodiesGenerationsBaseBehaviorBloodBlood DonationsBlood DonorGeneral PopulationBlood SpecimenBlood TestsBlood TransfusionCell LineCombinatorialCommercializationDetectionDiagnosisDiagnosticDiagnostic TestsBlood ScreeningEnzyme-Linked Immunosorbent AssayFda ApprovedGrant
Grant awards (4)
Improved Diagnosis of Kaposi's Sarcoma Herpes Virus Infection$602,714
R44 · FY2014 · CA · contact PI
Improved Diagnosis of Kaposi's Sarcoma Herpes Virus Infection$526,885
R44 · FY2013 · CA · contact PI
Improved Diagnosis of Kaposi's Sarcoma Herpes Virus Infection$667,906
R44 · FY2012 · CA · contact PI
Leptomycin B Analogs$300,000
R43 · FY2004 · CA